Franklin Genomic Advancements Etf (HELX) Technical Analysis

$35.21▲-0.03%

Market is closed - opens 8 PM, 11 Feb 2026

Insights

Franklin Genomic Advancements Etf is currently in a neutral trading position according to technical analysis indicators.
Based on analysis of the Oscillators technical indicator, the current market trend for Franklin Genomic Advancements Etf stock suggests that it is range bound and no decision can be made based on this information
Based on analysis of the Moving Averages technical indicator, Franklin Genomic Advancements Etf stock is in a downtrend↘️
Based on analysis of the Pivot Points, the current market trend for Franklin Genomic Advancements Etf stock suggests that it is a good time to buy

Analysis Summary

Oscillators

Sell

Neutral

Buy

Moving Averages

Sell

Neutral

Buy

Pivots

Sell

Neutral

Buy

Oscillators

Name	Value	Action
Relative Strength Index	38.28	Neutral
Stochastic	22.29, 13.27	Neutral
Ultimate Oscillator	38.47	Neutral
Stochastic Relative Strength Index	16.89, 8.82	Buy
Moving Average Convergence Divergence	-0.45, -0.17	Neutral

Moving Averages

Simple Moving Average

Period (Days)	Value	Action
10	36.14	Sell
20	36.76	Sell
50	36.95	Buy

Exponential Moving Average

Period (Days)	Value	Action
10	35.92	Sell
20	36.4	Buy
50	36.37	Buy

Volume Weighted Moving Average

Period (Days)	Value	Action
10	35.91	Neutral
20	36.88	Neutral
50	36.97	Neutral

Double Exponential Moving Average

Period (Days)	Value	Action
10	35.21	Sell
20	35.9	Sell
50	37.18	Sell

Triple Exponential Moving Average

Period (Days)	Value	Action
10	34.86	Sell
20	35.34	Sell
50	36.54	Sell

Pivot

Pivot	Value
Resistance L3	35.58
Resistance L2	35.31
Resistance L1	35.17
Pivot Point	34.9
Support L1	34.77
Support L2	34.49
Support L3	34.36

*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.